AETHLON MEDICAL INC (AEMD)
Data as of , from SEC Form 4 filings.
See up to 3 months of AEMD. The 7-day demo opens the 1M and 3M ranges and puts AEMD on your watchlist.
Start 7-day demoLatest AEMD insider trades
- Steven P. Larosa - OfficerGrant or award42,000 sh
Chetan Shah - DirectorTax withholding / forfeiture
About AETHLON MEDICAL INC (AEMD)
Aethlon Medical Inc is a medical therapeutic company focused on developing the Hemopurifier (HP), a clinical-stage investigational immunotherapeutic device designed to address unmet needs in oncology, life-threatening infectious diseases, organ transplantation and other disease states in which extracellular vesicles (EVs) contribute to disease progression. The Hemopurifier utilizes a proprietary lectin-based technology to bind and remove enveloped viruses and EVs from biological fluids. EVs have been associated with immune suppression, metastasis, and resistance to therapy in cancer, as well as progression of severe infectious diseases. The Company operates as a single reportable segment.
- SAN DIEGO, CA
- 9
- 1998
- Nasdaq
AEMD Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Grant or award | 3 | 105,815 | |
| Tax withholding / forfeiture | 3 | 1,090 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
AEMD insider transactions (Form 4)
3030 Form 4 filings on record, the earliest from Oct 1, 2024, newest first.
| Traded | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Steven P. Larosa - Officer | Grant or award | Common Stock | 42,000 footnote F1 | $0.00 | - | |
| ||||||
| Chetan Shah - Director | Tax withholding / forfeiture | Common Stock | 436 footnote F1 | $6.52 | $3K | |
| ||||||
| Angela Rossetti - Director | Grant or award | Common Stock | 21,815 footnote F1 | $11.45 | $50K | |
| ||||||
| Nicolas Gikakis - Director | Tax withholding / forfeiture | Common Stock | 436 footnote F1 | $6.52 | $3K | |
| ||||||
| Edward G. Broenniman - Director | Tax withholding / forfeiture | Common Stock | 218 footnote F1 | $6.52 | $1K | |
| ||||||
| James B. Frakes - Officer | Grant or award | Common Stock | 42,000 footnote F1 | $0.00 | - | |
| ||||||
| Chetan Shah - Director | Tax withholding / forfeiture | Common Stock | 2,182 footnote F1 | $4.10 | $2K | |
| ||||||
| Nicolas Gikakis - Director | Tax withholding / forfeiture | Common Stock | 2,182 footnote F1 | $4.10 | $2K | |
| ||||||
| Edward G. Broenniman - Director | Tax withholding / forfeiture | Common Stock | 1,091 footnote F1 | $4.10 | $895 | |
| ||||||
| Angela Rossetti - Director | Grant or award | Common Stock | 21,815 footnote F1 | $11.45 | $50K | |
| ||||||
| Chetan Shah - Director | Grant or award | Common Stock | 21,815 footnote F1 | $11.45 | $50K | |
| ||||||
| Edward G. Broenniman - Director | Grant or award | Common Stock | 21,815 footnote F1 | $11.45 | $50K | |
| ||||||
| Nicolas Gikakis - Director | Grant or award | Common Stock | 21,815 footnote F1 | $11.45 | $50K | |
| ||||||
| Chetan Shah - Director | Tax withholding / forfeiture | Common Stock | 178 footnote F1 | $10.95 | $390 | |
| ||||||
| Nicolas Gikakis - Director | Tax withholding / forfeiture | Common Stock | 178 footnote F1 | $10.95 | $390 | |
| ||||||
| Edward G. Broenniman - Director | Tax withholding / forfeiture | Common Stock | 89 footnote F1 | $10.95 | $195 | |
| ||||||
| Chetan Shah - Director | Tax withholding / forfeiture | Common Stock | 179 | $13.85 | $496 | |
| Nicolas Gikakis - Director | Tax withholding / forfeiture | Common Stock | 179 | $13.85 | $496 | |
| Edward G. Broenniman - Director | Tax withholding / forfeiture | Common Stock | 89 | $13.85 | $247 | |
| Nicolas Gikakis - Director | Tax withholding / forfeiture | Common Stock | 1,786 | $37.45 | $1K | |
| Chetan Shah - Director | Tax withholding / forfeiture | Common Stock | 1,786 | $37.45 | $1K | |
| Edward G. Broenniman - Director | Tax withholding / forfeiture | Common Stock | 893 | $37.45 | $669 | |
| Nicolas Gikakis - Director | Tax withholding / forfeiture | Common Stock | 1,786 | $60.00 | $2K | |
| Chetan Shah - Director | Tax withholding / forfeiture | Common Stock | 1,786 | $60.00 | $2K | |
| Edward G. Broenniman - Director | Tax withholding / forfeiture | Common Stock | 893 | $60.00 | $1K | |
| Edward G. Broenniman - Director | Grant or award | Common Stock | 142,857 | $140.00 | $50K | |
| Edward G. Broenniman - Director | Tax withholding / forfeiture | Common Stock | 1,645 | $143.20 | $589 | |
| Nicolas Gikakis - Director | Tax withholding / forfeiture | Common Stock | 3,289 | $186.40 | $2K | |
| Chetan Shah - Director | Tax withholding / forfeiture | Common Stock | 3,289 | $186.40 | $2K | |
| Edward G. Broenniman - Director | Tax withholding / forfeiture | Common Stock | 1,645 | $186.40 | $767 | |
Item 5.03, 9.01
Item 5.07
Item 5.02, 5.07, 9.01
Item 1.01, 5.01, 7.01, 9.01
AEMD insider trading FAQ
What is the latest insider trade for AEMD?
AETHLON MEDICAL INC (AEMD) had 6 insider filings in the last 90 days, with the most recent on 15 October 2026. The full record for AEMD runs to 30 Form 4 filings, the earliest from 1 October 2024. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying AEMD stock?
No insider purchases of AEMD were filed in the last 90 days.
How many insiders are selling AEMD stock?
No insider sales of AEMD were filed in the last 90 days.
Where can I see AEMD SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects AEMD Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Steven P. Larosa view on EDGAR
- - Chetan Shah view on EDGAR
- - Angela Rossetti view on EDGAR
- - Nicolas Gikakis view on EDGAR
- - Edward G. Broenniman view on EDGAR
- - James B. Frakes view on EDGAR
- - Chetan Shah view on EDGAR
- - Nicolas Gikakis view on EDGAR
- - Edward G. Broenniman view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Insider activity in Health Care
- Where AEMD's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow AEMD with a 7-day demo
- AEMD on your watchlist
- Every AEMD Form 4 filing on record
- Up to 3 months of AEMD price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.
